Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 2
2012 1
2014 2
2015 3
2016 1
2017 1
2018 3
2019 2
2020 7
2021 6
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial.
Prete A, Lanino E, Saglio F, Biffi A, Calore E, Faraci M, Rondelli R, Favre C, Zecca M, Casazza G, Porta F, Luksch R, Cesaro S, Rabusin M, Parasole R, Mura RM, Lo Nigro L, Leardini D, Pagliara D, Locatelli F, Fagioli F; AIEOP-BMT Group. Prete A, et al. Among authors: saglio f. Transplant Cell Ther. 2024 May;30(5):530.e1-530.e8. doi: 10.1016/j.jtct.2024.03.002. Epub 2024 Mar 7. Transplant Cell Ther. 2024. PMID: 38460729 Free article. Clinical Trial.
Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study.
Saglio F, Pagliara D, Zecca M, Balduzzi A, Cattoni A, Prete A, Tambaro FP, Faraci M, Calore E, Locatelli F, Fagioli F; AIEOP BMT Group. Saglio F, et al. Transplant Cell Ther. 2024 Apr;30(4):433.e1-433.e10. doi: 10.1016/j.jtct.2023.12.671. Epub 2024 Jan 2. Transplant Cell Ther. 2024. PMID: 38176654
Antibiotic prophylaxis and management of infections in pediatric hematopoietic stem cell transplantation: a survey from the Stem Cell Transplant and the Infectious Disease Working Groups of the AIEOP network.
Zama D, Masetti R, Baccelli F, Leardini D, Muratore E, Abram N, Vendemini F, Biffi A, Perruccio K, D'Amico MR, Faraci M, Tintori V, Spirito A, Lo Nigro L, Locatelli F, Luksch R, Saglio F, Santoro N, Soncini E, Zecca M, Ziino O, Prete A, Pagliara D, Cesaro S. Zama D, et al. Among authors: saglio f. Bone Marrow Transplant. 2022 Dec;57(12):1851-1853. doi: 10.1038/s41409-022-01793-5. Epub 2022 Oct 7. Bone Marrow Transplant. 2022. PMID: 36207623 No abstract available.
GATA2-related myeloid neoplasms in pediatrics: where do we stand?
Spadea M, Quarello P, Saglio F, Pedace L, Fagioli F. Spadea M, et al. Among authors: saglio f. Pediatr Hematol Oncol. 2022 May;39(4):365-369. doi: 10.1080/08880018.2021.1987600. Epub 2021 Oct 20. Pediatr Hematol Oncol. 2022. PMID: 34668827 No abstract available.
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.
Carnevale-Schianca F, Caravelli D, Gallo S, Becco P, Paruzzo L, Poletto S, Polo A, Mangioni M, Salierno M, Berger M, Pessolano R, Saglio F, Gottardi D, Rota-Scalabrini D, Grignani G, Fizzotti M, Ferrero I, Frascione PMM, D'Ambrosio L, Gaidano V, Gammaitoni L, Sangiolo D, Saglietto A, Vassallo E, Cignetti A, Aglietta M, Fagioli F. Carnevale-Schianca F, et al. Among authors: saglio f. J Clin Med. 2021 Mar 11;10(6):1173. doi: 10.3390/jcm10061173. J Clin Med. 2021. PMID: 33799685 Free PMC article.
30 results